Evidence map›Paper›PMID 37814070›Full record

ArticleNature microbiology2023

Systematic analyses identify modes of action of ten clinically relevant biocides and antibiotic antagonism in Acinetobacter baumannii.

Liping Li, Francesca L Short, Karl A Hassan, Varsha Naidu, Alaska Pokhrel, Stephanie S Nagy, Farzana T Prity, Bhumika S Shah, Nusrat Afrin, Stephen Baker and 3 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Highly Effective Biocides againstACS infectious diseases · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Liping LiARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0002-2994-6583
Francesca L ShortARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0002-0025-4858
Karl A HassanARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0003-2031-9679
Varsha NaiduARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.
Alaska PokhrelARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.
Stephanie S NagySchool of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0002-0814-6405
Farzana T PrityARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.
Bhumika S ShahARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0001-8968-440X
Nusrat AfrinSchool of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia.ORCID 0009-0008-8439-3791
Stephen BakerCambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, UK.
Julian ParkhillThe Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-7069-5958
Amy K CainARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia. amy.cain@mq.edu.au.ORCID 0000-0002-4230-6572
Ian T PaulsenARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, New South Wales, Australia. ian.paulsen@mq.edu.au.ORCID 0000-0001-9015-9418
ARC Centre of Excellence in Synthetic Biology · AUMacquarie University · AUUniversity of Cambridge · GBAustralian Institute of Business · AUDiscovery Institute · US

Funding

Department of Education and Training | Australian Research Council (ARC) DE180100929Department of Education and Training | Australian Research Council (ARC) DE200101524Department of Education and Training | Australian Research Council (ARC) FL140100021Department of Education and Training | Australian Research Council (ARC) FT180100123Department of Health | National Health and Medical Research Council (NHMRC) APP1060895Department of Health | National Health and Medical Research Council (NHMRC) APP1127615Department of Health | National Health and Medical Research Council (NHMRC) APP1165135Wellcome Trust (Wellcome) WT098051Wellcome Trust (Wellcome) WT100087/Z/12/Z
6 · The paper itself

Abstract

Concerns exist that widespread use of antiseptic or disinfectant biocides could contribute to the emergence and spread of multidrug-resistant bacteria. To investigate this, we performed transposon-directed insertion-site sequencing (TraDIS) on the multidrug-resistant pathogen, Acinetobacter baumannii, exposed to a panel of ten structurally diverse and clinically relevant biocides. Multiple gene targets encoding cell envelope or cytoplasmic proteins involved in processes including fatty acid biogenesis, multidrug efflux, the tricarboxylic acid cycle, cell respiration and cell division, were identified to have effects on bacterial fitness upon biocide exposure, suggesting that these compounds may have intracellular targets in addition to their known effects on the cell envelope. As cell respiration genes are required for A. baumannii fitness in biocides, we confirmed that sub-inhibitory concentrations of the biocides that dissipate membrane potential can promote A. baumannii tolerance to antibiotics that act intracellularly. Our results support the concern that residual biocides might promote antibiotic resistance in pathogenic bacteria.

Indexed as

Acinetobacter baumanniiDisinfectantsAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialAnti-Bacterial AgentsDisinfectants

Identifiers

PMID37814070
OpenAlexW4387451446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.